Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease that impacts the body’s connective tissues, including cartilage and the lining of the blood vessels. Symptoms often include fatigue, a vague feeling of discomfort or illness, fever, loss of appetite, weight loss, and joint pain.

For patients that have a confirmed lupus diagnosis, taking part in a clinical trial may be an option for exploring new treatment options that help manage and control these symptoms.